Jia, Y., Lu, N., He, L., Shi, Y., Tong, Z. (2025). Efficacy and safety of dalpiciclib plus toremifene in advanced HR-positive HER2-negative breast cancer as first-line treatment: A multicenter, single-arm phase II trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e13062